p53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
p53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer
Authors
Keywords
Thomsen–Friedenreich, Epitope, CD176, TF1, p53, Ovarian cancer, Prognosis
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 142, Issue 6, Pages 1163-1170
Publisher
Springer Nature
Online
2016-03-02
DOI
10.1007/s00432-016-2126-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical studies with JAA-F11 anti-Thomsen-Friedenreich monoclonal antibody for human breast cancer
- (2014) Kimiko Ferguson et al. Future Oncology
- The G-Protein Coupled Estrogen Receptor (GPER/GPR30) is a Gonadotropin Receptor Dependent Positive Prognosticator in Ovarian Carcinoma Patients
- (2013) Sabine Heublein et al. PLoS One
- Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)
- (2013) Sabine Heublein et al. Journal of Ovarian Research
- What makes cancer stem cell markers different?
- (2013) Uwe Karsten et al. SpringerPlus
- Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients
- (2012) Verena Engelstaedter et al. BMC CANCER
- Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer
- (2012) Miriam Lenhard et al. BMC CANCER
- Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival
- (2012) Miriam Lenhard et al. BMC CANCER
- Correlation between P53 expression and malignant risk of gastrointestinal stromal tumors: Evidence from 9 studies
- (2011) L. Zong et al. EJSO
- Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival
- (2011) Miriam Lenhard et al. HISTOPATHOLOGY
- The Association between Vitamin D Receptor Expression and Prolonged Overall Survival in Breast Cancer
- (2011) Nina Ditsch et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis
- (2011) Anna Yemelyanova et al. MODERN PATHOLOGY
- Histomolecular classification of adult diffuse gliomas: The diagnostic value of immunohistochemical markers
- (2011) D. Figarella-Branger et al. REVUE NEUROLOGIQUE
- Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells
- (2010) Wei-Ming Lin et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Molecular Characterization of 103 Ovarian Serous and Mucinous Tumors
- (2010) Ildikó Vereczkey et al. PATHOLOGY & ONCOLOGY RESEARCH
- Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis
- (2009) P de Graeff et al. BRITISH JOURNAL OF CANCER
- A comparison between p53 accumulation determined by immunohistochemistry andTP53mutations as prognostic variables in tumours from breast cancer patients
- (2008) Jan Alsner et al. ACTA ONCOLOGICA
- TP53, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with taxane-platinum regimens
- (2008) Izabela Ziółkowska-Seta et al. GYNECOLOGIC ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search